Trastuzumab Deruxtecan Alone or in Combination With Anastrozole for the Treatment of Early Stage HER2 Low, Hormone Receptor Positive Breast Cancer
Trastuzumab Deruxtecan Alone or in Combination With Anastrozole for the Treatment of Early Stage HER2 Low, Hormone Receptor Positive Breast Cancer
Recruiting · NCT04553770 · Registry updated 2025-11-10Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Trastuzumab Deruxtecan Alone or in Combination With Anastrozole for the Treatment of Early Stage HER2 Low, Hormone Receptor Positive Breast Cancer | Neoplasms by Site, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, invasive breast carcinoma, neoplasm, skin disorder | Recruiting | Phase 2 | 2025-11-10 | NCT04553770 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Daiichi Sankyo Co., Ltd. | 14 |
| Jonsson Comprehensive Cancer Center | 115 |
| Translational Research in Oncology | 9 |
9 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Cancer Blood and Specialty Clinic | Los Alamitos | United States | 5 |
| Cancer Center of Kansas | Wichita | United States | 21 |
| Ft. Wayne Medical Oncology and Hematology, Inc. | Fort Wayne | United States | 2 |
| Massachusetts General Hospital | Boston | United States | 1015 |
| Orlando Health, Inc. d/b/a Orlando Health UF Health Center | Orlando | United States | 2 |
| PIH Health | Whittier | United States | 4 |
| St. Joseph Heritage Healthcare | Fullerton | United States | 2 |
| Torrance Memorial Physician Network / Cancer Care | Torrance | United States | 1 |
| UCLA / Jonsson Comprehensive Cancer Center | Los Angeles | United States | 126 |